Max Theiler received the Nobel Prize in Physiology or Medicine in 1951 for discoveries concerning yellow fever and ways to combat it. Born in Pretoria in 1899, he became part of an international research effort. This account examines the historical achievement rather than offering present-day vaccination advice.
Theiler's education included study in South Africa before further medical training in Britain. He joined Harvard's tropical medicine department in 1922 and moved to the Rockefeller Foundation in 1930. The route connects African beginnings with research institutions where the work later recognised by Nobel developed.
An important part of that work concerned making yellow fever easier to investigate in the laboratory. The Nobel biography describes his role in establishing that a virus, rather than a bacterium, caused the disease. It also explains how work using mice made experiments less costly than earlier research involving monkeys.
The Nobel facts page identifies 1937 as the year Theiler obtained a weakened virus variant known as 17D, which became the basis of a human vaccine. That date belongs to the development history. The later 1951 award recognised the contribution; it was not the year the vaccine work began.
The story is therefore about several connected achievements: understanding an infectious agent, developing experimental methods and turning research into a usable approach to prevention. Giving one scientist an award does not mean that these steps occurred without colleagues, institutions or the accumulated work of other researchers.
For readers interested in African scientific excellence, Theiler's career broadens the picture beyond a single laboratory or national border. It also demonstrates why scientific histories need careful dates. Discovery, development and recognition can occur years apart, and keeping them distinct makes the achievement easier to understand.